Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

QUESTION 1. Normal CSF: does it exclude meningitis?

Ray B, Rylance G.

Arch Dis Child. 2009 Dec;94(12):988-91. doi: 10.1136/adc.2009.163766. Review. No abstract available.

PMID:
19933606
2.

Emergency management of anaphylaxis in children and young people: new guidance from the Resuscitation Council (UK).

Tse Y, Rylance G.

Arch Dis Child Educ Pract Ed. 2009 Aug;94(4):97-101. doi: 10.1136/adc.2007.120378. No abstract available. Erratum in: Arch Dis Child Educ Pract Ed. 2010 Dec;95(12):1071.

PMID:
19654399
3.

Emergency treatment of anaphylactic reactions--guidelines for healthcare providers.

Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, Ewan P, Foëx B, Gabbott D, Griffiths M, Hall J, Harper N, Jewkes F, Maconochie I, Mitchell S, Nasser S, Nolan J, Rylance G, Sheikh A, Unsworth DJ, Warrell D; Working Group of the Resuscitation Council (UK).

Resuscitation. 2008 May;77(2):157-69. doi: 10.1016/j.resuscitation.2008.02.001. Epub 2008 Mar 20.

PMID:
18358585
4.

Topographical complexity of multidimensional energy landscapes.

Rylance GJ, Johnston RL, Matsunaga Y, Li CB, Baba A, Komatsuzaki T.

Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18551-5. Epub 2006 Nov 28.

5.

The launch of the British National Formulary for Children.

Elias-Jones A, Rylance G.

Arch Dis Child. 2005 Oct;90(10):997-8. No abstract available.

6.

How many dimensions are required to approximate the potential energy landscape of a model protein?

Komatsuzaki T, Hoshino K, Matsunaga Y, Rylance GJ, Johnston RL, Wales DJ.

J Chem Phys. 2005 Feb 22;122(8):84714.

PMID:
15836084
7.

How do paediatricians communicate with children and parents?

Wassmer E, Minnaar G, Abdel Aal N, Atkinson M, Gupta E, Yuen S, Rylance G.

Acta Paediatr. 2004 Nov;93(11):1501-6.

PMID:
15513580
8.

Training in paediatric clinical pharmacology in the UK.

Choonara I, Dewit O, Harrop E, Haworth S, Helms P, Kanabar D, Lenney W, Rylance G, Vallance P.

Br J Clin Pharmacol. 2004 Aug;58(2):217-8. Erratum in: Br J Clin Pharmacol. 2004 Nov;58(5):563. Howarth, Sheila [corrected to Haworth, Sheila].

9.

Protein substitutes for PKU: what's new?

Macdonald A, Daly A, Davies P, Asplin D, Hall SK, Rylance G, Chakrapani A.

J Inherit Metab Dis. 2004;27(3):363-71. Review.

PMID:
15190194
10.

Free use of fruits and vegetables in phenylketonuria.

MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW.

J Inherit Metab Dis. 2003;26(4):327-38.

PMID:
12971420
11.

Administration of protein substitute and quality of control in phenylketonuria: a randomized study.

MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW.

J Inherit Metab Dis. 2003;26(4):319-26.

PMID:
12971419
12.

Are tablets a practical source of protein substitute in phenylketonuria?

MacDonald A, Ferguson C, Rylance G, Morris AA, Asplin D, Hall SK, Booth IW.

Arch Dis Child. 2003 Apr;88(4):327-9.

13.

Poisoning in children 5: rare and dangerous poisons.

Riordan M, Rylance G, Berry K.

Arch Dis Child. 2002 Nov;87(5):407-10. Review. No abstract available.

14.

Poisoning in children 4: household products, plants, and mushrooms.

Riordan M, Rylance G, Berry K.

Arch Dis Child. 2002 Nov;87(5):403-6. Review. No abstract available.

15.

Poisoning in children 3: common medicines.

Riordan M, Rylance G, Berry K.

Arch Dis Child. 2002 Nov;87(5):400-2. Review. No abstract available.

16.

Poisoning in children 2: painkillers.

Riordan M, Rylance G, Berry K.

Arch Dis Child. 2002 Nov;87(5):397-9. Review. No abstract available.

17.

Poisoning in children 1: general management.

Riordan M, Rylance G, Berry K.

Arch Dis Child. 2002 Nov;87(5):392-6. Review. No abstract available. Erratum in: Arch Dis Child. 2003 Oct;88(10):946.

18.

The impact of phenylketonuria on folate metabolism.

Lucock M, Yates Z, Hall K, Leeming R, Rylance G, MacDonald A, Green A.

Mol Genet Metab. 2002 Aug;76(4):305-12.

PMID:
12208135
19.

How practical are recommendations for dietary control in phenylketonuria?

Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A.

Lancet. 2002 Jul 6;360(9326):55-7.

PMID:
12114043
20.

Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency.

Chambliss KL, Gray RG, Rylance G, Pollitt RJ, Gibson KM.

J Inherit Metab Dis. 2000 Jul;23(5):497-504.

PMID:
10947204
21.

Nut allergy in children.

Armstrong D, Rylance G.

Arch Dis Child. 2000 May;82(5):428. No abstract available.

22.

Definitive diagnosis of nut allergy.

Armstrong D, Rylance G.

Arch Dis Child. 1999 Feb;80(2):175-7.

23.

Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations.

Hutchesson AC, Murdoch-Davis C, Green A, Preece MA, Allen J, Holton JB, Rylance G.

J Inherit Metab Dis. 1999 Apr;22(2):139-48.

PMID:
10234609
24.

Privacy, dignity, and confidentiality: interview study with structured questionnaire.

Rylance G.

BMJ. 1999 Jan 30;318(7179):301. No abstract available.

25.

Does a single plasma phenylalanine predict quality of control in phenylketonuria?

MacDonald A, Rylance GW, Asplin D, Hall SK, Booth IW.

Arch Dis Child. 1998 Feb;78(2):122-6.

26.

Children have rights to medicines.

Essex C, Rylance G.

BMJ. 1997 Jul 5;315(7099):62. No abstract available.

27.

Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet.

MacDonald A, Rylance G, Hall SK, Asplin D, Booth IW.

Arch Dis Child. 1996 May;74(5):412-7.

28.

Making decisions with children.

Rylance G.

BMJ. 1996 Mar 30;312(7034):794. No abstract available.

29.

Measles and rubella immunisation: information and consent in children.

Rylance G, Bowen C, Rylance J.

BMJ. 1995 Oct 7;311(7010):923-4. No abstract available.

30.

Feeding problems in young PKU children.

MacDonald A, Rylance GW, Asplin DA, Hall K, Harris G, Booth IW.

Acta Paediatr Suppl. 1994 Dec;407:73-4.

PMID:
7766964
31.

Inappropriate prescribing of promethazine in infants.

Pollard AJ, Rylance G.

Arch Dis Child. 1994 Apr;70(4):357. No abstract available.

32.

Guillain-Barré syndrome after measles, mumps, and rubella vaccine.

Morris K, Rylance G.

Lancet. 1994 Jan 1;343(8888):60. No abstract available.

PMID:
7905077
33.
34.

Consumer safety and child choking attacks.

Sunderland R, Rylance G.

Arch Dis Child. 1992 May;67(5):664. No abstract available.

35.

Drugs and breast milk.

Rylance G, Plant N.

Practitioner. 1991 Sep;235(1506):692-4. No abstract available.

PMID:
1796036
36.

Parental permission, information, and consent.

Fell JM, Rylance GW.

Arch Dis Child. 1991 Aug;66(8):980-1.

37.

Prescribing for children.

Plant N, Rylance G.

Practitioner. 1991 Apr;235(1501):364-6. No abstract available.

PMID:
1857675
38.

Consenting patients.

Fell JM, Rylance GW.

BMJ. 1990 Nov 10;301(6760):1102-3. No abstract available.

39.

Neurological deterioration in young adults with phenylketonuria.

Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ.

Lancet. 1990 Sep 8;336(8715):602-5.

PMID:
1975386
40.

Treatment of epilepsy and febrile convulsions in children.

Rylance GW.

Lancet. 1990 Aug 25;336(8713):488-91. Review. No abstract available.

PMID:
1975000
41.

Patients' right to know.

Rylance G.

BMJ. 1990 Mar 3;300(6724):608-9. No abstract available.

42.

Rapid anticonvulsant monitoring in an epilepsy clinic.

Houtman PN, Hall SK, Green A, Rylance GW.

Arch Dis Child. 1990 Mar;65(3):264-8.

43.

Juvenile granulosa cell tumor.

Raafat F, Klys H, Rylance G.

Pediatr Pathol. 1990;10(4):617-23. Review.

PMID:
2196546
44.

Informing patients.

Rylance G.

Lancet. 1989 Oct 14;2(8668):922. No abstract available.

PMID:
2571842
45.

Outcome of early detected and early treated phenylketonuria patients.

Rylance G.

Postgrad Med J. 1989;65 Suppl 2:S7-9.

PMID:
2622815
46.

Use of drugs by children.

Rylance GW, Woods CG, Cullen RE, Rylance ME.

BMJ. 1988 Aug 13;297(6646):445-7.

47.

Prescribing for infants and children.

Rylance GW.

Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):984-6. Review. No abstract available.

48.

Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy.

Edwards MA, Green A, Colli A, Rylance G.

Lancet. 1987 Jun 20;1(8547):1437-8. No abstract available.

PMID:
2884531
49.

Carbimazole and breastfeeding.

Rylance GW, Woods CG, Donnelly MC, Oliver JS, Alexander WD.

Lancet. 1987 Apr 18;1(8538):928. No abstract available.

PMID:
2882332
50.

Adverse reactions to drugs in children.

Woods CG, Rylance ME, Cullen RE, Rylance GW.

Br Med J (Clin Res Ed). 1987 Apr 4;294(6576):869-70. No abstract available.

Supplemental Content

Loading ...
Support Center